New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

E-ISSN： 1873-4286|19|4|734-744

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.4, 2013-02, pp. : 734-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases

Current Drug Targets, Vol. 11, Iss. 11, 2010-11 ,pp. : 1430-1438

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors: insights into mechanisms of lethality

By Rosato Roberto R Grant Steven

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 809-824

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 519-527

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: New Hope for Rheumatoid Arthritis?

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 803-820

Bentham Science Publishers

Access to resources Recommend Favorite

Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3467-3479

Bentham Science Publishers

Access to resources Recommend Favorite